ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/07/21 | 日証協 | 308,480株 | +11.58% | 78,350株 | +449.25% | 383,957株 | +2.22% | 56,116株 | +292.42% |
2017/07/14 | 日証協 | 276,470株 | -0.68% | 14,265株 | -64.58% | 375,631株 | +0.75% | 14,300株 | -73.43% |
2017/07/07 | 日証協 | 278,370株 | +32.07% | 40,270株 | -82.71% | 372,831株 | +8.23% | 53,824株 | -66.32% |
2017/06/30 | 日証協 | 210,776株 | +101.7% | 232,970株 | +8943.87% | 344,467株 | +52.71% | 159,800株 | +239.57% |
2017/06/23 | 日証協 | 104,500株 | -0.19% | 2,576株 | +71.73% | 225,567株 | +17.66% | 47,060株 | +406.02% |
2017/06/16 | 日証協 | 104,700株 | -0.29% | 1,500株 | -82.56% | 191,712株 | +3.01% | 9,300株 | -59.74% |
2017/06/09 | 日証協 | 105,000株 | -10.23% | 8,600株 | +69.66% | 186,112株 | +12.53% | 23,100株 | -44.95% |
2017/06/02 | 日証協 | 116,969株 | +17.4% | 5,069株 | -97.02% | 165,396株 | +110.19% | 41,959株 | -78.9% |
2017/05/26 | 日証協 | 99,629株 | +52.88% | 170,069株 | +698.11% | 78,690株 | -34.09% | 198,900株 | +3652.83% |
2017/05/19 | 日証協 | 65,169株 | -12.34% | 21,309株 | -62.88% | 119,391株 | -19.54% | 5,300株 | -60.57% |
2017/05/12 | 日証協 | 74,340株 | -9.31% | 57,400株 | +33.49% | 148,391株 | +2.98% | 13,440株 | +540% |
2017/05/02 | 日証協 | 81,970株 | +6.91% | 43,000株 | -8.9% | 144,096株 | +3.52% | 2,100株 | -91.22% |
2017/04/28 | 日証協 | 76,670株 | -31.78% | 47,200株 | +73% | 139,190株 | -22.28% | 23,906株 | +71.99% |
2017/04/21 | 日証協 | 112,380株 | -7.12% | 27,283株 | +21.65% | 179,090株 | +4.43% | 13,900株 | -87.13% |
2017/04/14 | 日証協 | 120,990株 | -23.86% | 22,427株 | +121.61% | 171,490株 | +46.84% | 108,000株 | +1036.84% |
2017/04/07 | 日証協 | 158,900株 | +2.32% | 10,120株 | -90.55% | 116,790株 | +3.49% | 9,500株 | +21.02% |
2017/03/31 | 日証協 | 155,300株 | -29.51% | 107,120株 | +4326.45% | 112,850株 | -45.87% | 7,850株 | +106.04% |
2017/03/24 | 日証協 | 220,300株 | -1.22% | 2,420株 | +51.25% | 208,490株 | -0.92% | 3,810株 | -42.27% |
2017/03/17 | 日証協 | 223,030株 | -3.34% | 1,600株 | -97.24% | 210,420株 | -4.62% | 6,600株 | -89% |
※株式分割は考慮していませんのでご注意ください。
Page Top